Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

Réseaux Appels à projets Actualités
375 publications
Année de publication :
Réseaux :

Use of radiomics in the radiation oncology setting: Where do we stand and what do we…

Radiomics is a field that has been growing rapidly for the past ten years in medical imaging and more particularly in oncology where the primary objective is to contribute to personalised and predictive medicine.

  • Ref: Cancer Radiother. 2020 Oct;24(6-7):755-761.
  • Année de publication : 2020
  • Auteurs : Schick U, Lucia F, Bourbonne V, Dissaux G, Pradier O, Jaouen V, Tixier F, Visvikis D, Hatt M.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

68Ga-Labelled Carbon Nanoparticles for Ventilation PET/CT Imaging: Physical Properties Study and Comparison with Technegas®.

The alternative analysis of A. Bianchi and M. Savastano is a valuable contribution to the understanding of the complex systems at stake in the complexation chemistry of Zr4+ by considering polynuclear species.

  • Ref: Mol Imaging Biol. 2020 Sep 4.
  • Année de publication : 2020
  • Auteurs : Blanc-Béguin F, Eliès P, Robin P, Tripier R, Kervarec N, Lemarié CA, Hennebicq S, Tromeur C, Cogulet V, Salaün PY, Le Roux PY.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Reply to the ‘Comment on “Investigation of Zr(iv) and 89Zr(iv) complexation with hydroxamates: progress towards designing…

The alternative analysis of A. Bianchi and M. Savastano is a valuable contribution to the understanding of the complex systems at stake in the complexation chemistry of Zr4+ by considering polynuclear species.

  • Ref: Chem Commun (Camb). 2020 Oct 25;56(83):12667-12668.
  • Année de publication : 2020
  • Auteurs : Guérard F, Lee YS, Tripier R, Szajek LP, Deschamps JR, Brechbiel MW.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal…

Despite therapeutic progress in recent years with the introduction of targeted therapies (daratumumab, elotuzumab), multiple myeloma remains an incurable cancer.

  • Ref: Cancers (Basel). 2020 Sep 22;12(9):2721.
  • Année de publication : 2020
  • Auteurs : Gouard S, Maurel C, Marionneau-Lambot S, Dansette D, Bailly C, Guérard F, Chouin N, Haddad F, Alliot C, Gaschet J, Eychenne R, Kraeber-Bodéré F, Chérel M.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients.

Background: Multiple myeloma is a hematological neoplasm characterized by a clonal proliferation of malignant plasma cells in the bone marrow, and is associated with high morbidity and mortality and variable survival.

  • Ref: Cancers (Basel). 2020 Sep 6;12(9):2532.
  • Année de publication : 2020
  • Auteurs : Michaud-Robert AV, Zamagni E, Carlier T, Bailly C, Jamet B, Touzeau C, Moreau P, Kraeber-Bodere F, Nanni C, Bodet-Milin C.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics.

Purpose: Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is included in the International Myeloma Working Group (IMWG) imaging guidelines for the work-up at diagnosis and the follow-up of multiple myeloma (MM) notably because it is a reliable tool as a predictor of prognosis.

  • Ref: Eur J Nucl Med Mol Imaging. 2020 Oct 2.
  • Année de publication : 2020
  • Auteurs : Jamet B, Morvan L, Nanni C, Michaud AV, Bailly C, Chauvie S, Moreau P, Touzeau C, Zamagni E, Bodet-Milin C, Kraeber-Bodéré F, Mateus D, Carlier T.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Treatment of radiation-induced late effects: What’s new?

Mechanisms of late radio-induced lesions are the result of multiple and complex phenomena, with many entangled cellular and tissue factors.

  • Ref: Cancer Radiother. 2020 Oct;24(6-7):602-611.
  • Année de publication : 2020
  • Auteurs : Chargari C, Supiot S, Hennequin C, Chapel A, Simon JM.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms.

Osteosarcoma (OS) is the most common cancer of bone. Jaw osteosarcoma (JOS) is rare and it differs from long-bone OS (LBOS) in terms of the time of onset (two decades later), lower metastatic spread, and better survival.

  • Ref: Crit Rev Oncol Hematol. 2020 Oct 10;156:103126.
  • Année de publication : 2020
  • Auteurs : Bertin H, Gomez-Brouchet A, Rédini F.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Long-term Trace of Radiation Pneumonitis With 18F-Fluoroestradiol.

Radiation pneumonitis (RP) can be an adverse complication of radiotherapy and usually occurs as an acute reaction from 6 to 12 weeks after radiotherapy.

  • Ref: Clin Nucl Med. 2020 Sep;45(9):e403-e405.
  • Année de publication : 2020
  • Auteurs : Morel A, Maucherat B, Chiavassa S, Kraeber-Bodéré F, Rousseau C.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy.

Identified in 1973, somatostatin (SST) is a cyclic hormone peptide with a short biological half-life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five subtypes described.

  • Ref: Molecules. 2020 Sep 2;25(17):4012.
  • Année de publication : 2020
  • Auteurs : Eychenne R, Bouvry C, Bourgeois M, Loyer P, Benoist E, Lepareur N.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication